1. Home
  2. SAIA vs BIO Comparison

SAIA vs BIO Comparison

Compare SAIA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saia Inc.

SAIA

Saia Inc.

N/A

Current Price

$344.41

Market Cap

9.4B

Sector

Industrials

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$357.71

Market Cap

10.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SAIA
BIO
Founded
1924
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
10.1B
IPO Year
2002
1994

Fundamental Metrics

Financial Performance
Metric
SAIA
BIO
Price
$344.41
$357.71
Analyst Decision
Buy
Hold
Analyst Count
21
3
Target Price
★ $434.38
$328.33
AVG Volume (30 Days)
★ 283.4K
230.5K
Earning Date
10-29-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 142.61
EPS
★ 5.37
N/A
Revenue
★ $3,234,286,000.00
$2,583,200,000.00
Revenue This Year
$11.65
N/A
Revenue Next Year
$7.45
$2.47
P/E Ratio
$62.86
★ N/A
Revenue Growth
★ 0.79
0.65
52 Week Low
$249.32
$236.73
52 Week High
$494.71
$396.23

Technical Indicators

Market Signals
Indicator
SAIA
BIO
Relative Strength Index (RSI) 38.21 48.40
Support Level $308.92 $364.41
Resistance Level $345.84 $392.81
Average True Range (ATR) 10.45 9.33
MACD -0.21 -1.87
Stochastic Oscillator 18.02 33.74

Price Performance

Historical Comparison
SAIA
BIO

About SAIA Saia Inc.

Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 210 facilities and a fleet of more than 7,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: